Plain-English translation of NCT07486401 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether checking a simple blood marker (called eosinophils) can help doctors manage asthma more effectively in primary care. Half of the participants will receive standard asthma care, while the other half will have their treatment guided by blood eosinophil counts. The researchers believe that using this blood test result may help reduce asthma attacks, improve symptom control, and make daily life better for people with mild to moderate asthma.
Many people with asthma don't have good control of their symptoms, even when taking medication. Doctors want to know if a simple blood test can help them personalize treatment and prevent asthma attacks before they happen, rather than treating everyone the same way.
You likely qualify if…
You likely don't qualify if…
You will visit your doctor about every 4 months for 1 year. Half of participants will receive usual asthma care, while the other half will have blood tests done to check eosinophil levels, and their asthma treatment will be adjusted based on those results. Both groups will be monitored to see how many asthma attacks they have, how well they're breathing, and how the treatment affects their quality of life.
AI-generated summary from trial data · Jun 14, 2026 · Not medical advice
Singapore